[-] Show simple item record

dc.contributor.authorTash, Joseph S.
dc.contributor.corporatenameUniversity of Missouri (System)en
dc.contributor.meetingnameMissouri Life Sciences Summit (2010: University of Missouri--Kansas City)en
dc.date.issued2010-03
dc.descriptionScientifically Led National Enterprises Panelen
dc.description.abstractNearly five decades have elapsed since the development of the female contraceptive hormone pill. During this time numerous alternative female contraceptive methods have also gained acceptance, however “the pill” and other hormone-based female contraceptive methods remain the most widely used. There are many couples where the female cannot use existing methods. For the male, effective contraceptive methods are limited to condoms and vasectomy. NIH, WHO, and the National Academy of Science Institute of Medicine have all stressed the need to develop new non-hormonal contraceptive methods. In the US, 30% of men use these male methods, so there is already a significant acceptance of male alternatives for actively participating in family planning. My basic research in male reproductive biology has always focused on identifying regulators of sperm or testis function that could be employed to develop a male contraceptive.en
dc.identifier.urihttp://hdl.handle.net/10355/6830
dc.relation.ispartofPresentations (Missouri Regional Life Sciences Summit 2010)en
dc.relation.ispartofcommunityUniversity of Missouri System. Missouri Summits. Missouri Regional Life Sciences Summit 2010.
dc.subjectbirth controlen
dc.subjectdrug developmenten
dc.subjectnon-hormonal contraceptive methodsen
dc.subject.lcshBirth controlen
dc.subject.lcshOral contraceptives, Maleen
dc.subject.lcshContraceptivesen
dc.titleThe “Male Pill”: The Learning Curve from Basic Science to the Drug Development Pipeline and the Strength of Interdisciplinary Collaborationen
dc.typePresentationen


Files in this item

[PDF]
Thumbnail

This item appears in the following Collection(s)

[-] Show simple item record